Friday, March 03, 2023 1:44:33 PM
That kind of news and this news make it clear, we made the right choice with $RVVTF and Bucillamine
This news confirms what I have been saying all along:
https://www.ehealthme.com/vs/moderna-covid-vaccine/rheumatoid-factor-increased/
You and I knew this because we have battled RA (rheumatoid-factor...)
The "rheumatoid-factor" is a blood test confirming one has RA.
Mine was so high in 2014, they could not even measure it, it was off the scale.
This proves what I have been saying that RA drugs, like Bucillamine are the key, and among them all Bucillamine has many advantages...
This could be a 5 billion stock based on using Bucillamine world wide for Covid19 and long haul covid19...
The vaccines force the body to make the make Covid19 spikes that set off the Autoimmune issues, just as the covid19 virus itself does....
I am buying more before the big news....
This news confirms what I have been saying all along:
https://www.ehealthme.com/vs/moderna-covid-vaccine/rheumatoid-factor-increased/
You and I knew this because we have battled RA (rheumatoid-factor...)
The "rheumatoid-factor" is a blood test confirming one has RA.
Mine was so high in 2014, they could not even measure it, it was off the scale.
This proves what I have been saying that RA drugs, like Bucillamine are the key, and among them all Bucillamine has many advantages...
This could be a 5 billion stock based on using Bucillamine world wide for Covid19 and long haul covid19...
The vaccines force the body to make the make Covid19 spikes that set off the Autoimmune issues, just as the covid19 virus itself does....
I am buying more before the big news....
Bullish
Recent RVVTF News
- Revive Therapeutics Strengthens Bucillamine IP Portfolio with North American Patent Filings for Nerve Agent Exposure and Granted Canadian Patent for Infectious Diseases • ACCESS Newswire • 03/11/2026 11:30:00 AM
- Revive Therapeutics Provides Update of Key Nerve Agent Countermeasure Study • GlobeNewswire Inc. • 12/15/2025 12:30:00 PM
- Revive Therapeutics Provides Update of Key Nerve Agent Countermeasure Study • GlobeNewswire Inc. • 11/21/2025 05:07:49 PM
- Revive Therapeutics Announces Closing of Second Tranche of Private Placement • GlobeNewswire Inc. • 09/19/2025 09:00:28 PM
